Clinical trial
HPV Self-sampling in the General Population: Efficacy, Feasibility, Acceptability and Cost-effectiveness
NCT06749847 is registered in ClinicalTrials.gov with International Agency for Research on Cancer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HPV Self-sampling in the General Population: Efficacy, Feasibility, Acceptability and Cost-effectiveness
- Lead sponsor
- International Agency for Research on Cancer
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 26, 2025
- Completion date
- December 31, 2026
- Enrollment
- 6,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer